Stocklytics Platform
Asset logo for symbol KURA
Kura Oncology
KURA47
$7.25arrow_drop_up0.27%$0.01
Asset logo for symbol KURA
KURA47

$7.25

arrow_drop_up0.27%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Kura Oncology (KURA) Stocklytics Forecast

Kura Oncology Inc (KURA) is a biopharmaceutical company that focuses on the discovery and development of precision medicines for the treatment of cancer. The company is dedicated to delivering innovative therapies that address the unmet needs of patients with cancer. With a strong pipeline of potential drugs, Kura Oncology is well-positioned to make a significant impact in the field of oncology.
The stock price of Kura Oncology Inc has shown great potential for growth in recent years. Analysts predict that the stock will continue to perform well in the coming years, with a positive outlook for the year 2023. The stock has been steadily gaining momentum, driven by the company's robust clinical pipeline and promising drug candidates. The market has recognized the value of Kura Oncology's innovative approach to cancer treatment, resulting in increased investor interest and a positive trend in the stock price.
add Kura Oncology to watchlist

Keep an eye on Kura Oncology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Kura Oncology (KURA) stock?

Analysts have set a target price of $29.43 for Kura Oncology (KURA), based on forecasts from 29 analysts. The predicted price range extends from a high of $40 to a low of $10.5. This represents a potential increase of up to 451.72% and a decrease of 44.83% from the current price of $7.25. These forecasts are as of 2021 Aug 06.
help

What are the analyst ratings for Kura Oncology (KURA) stock?

The analyst ratings for Kura Oncology (KURA) are distributed as follows: 14 analysts recommend buying, 2 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 16 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Kura Oncology .
help

What is the AI price prediction for Kura Oncology (KURA) stock?

At present, there is no AI or machine-learning-based price prediction available for Kura Oncology (KURA) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level